Home
About
Overview
Sharing Data
ORCID
Help
History (16)
Selection of Head and Neck Cancer Patients for Intensive Therapy.
Taming hemodialysis-induced inflammation: Are complement C3 inhibitors a viable option?
Application of stem cell derived neuronal cells to evaluate neurotoxic chemotherapy.
Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity?
RLIP inhibition suppresses breast-to-lung metastasis.
See All 16 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
RLIP inhibition suppresses breast-to-lung metastasis.
RLIP inhibition suppresses breast-to-lung metastasis. Cancer Lett. 2019 04 10; 447:24-32.
View in:
PubMed
subject areas
Animals
ATP-Binding Cassette Transporters
Breast
Breast Neoplasms
Cell Line, Tumor
Cell Survival
Female
Flavanones
GTPase-Activating Proteins
Humans
Lung
Lung Neoplasms
Mice
Mice, Inbred NOD
Mice, SCID
Neoplasm Metastasis
Xenograft Model Antitumor Assays
authors with profiles
Ravi Salgia